Oramed Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
03 Apr 23 | BuyUS$19,518 | Arie Mayer | Individual | 8,809 | US$2.22 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 586 | 0.00145% |
Individual Insiders | 3,821,629 | 9.43% |
Institutions | 5,540,929 | 13.7% |
General Public | 31,156,016 | 76.9% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
1,906,667 | US$5.3m | 0.26% | no data | |||
1,261,559 | US$3.5m | 61.5% | 2.57% | |||
1,165,879 | US$3.2m | 1.46% | no data | |||
1,050,000 | US$2.9m | 0% | 0.58% | |||
525,001 | US$1.4m | 0% | 0.06% | |||
341,073 | US$941.4k | 670% | no data | |||
289,803 | US$799.9k | 0% | no data | |||
283,600 | US$782.7k | 71.3% | no data | |||
259,010 | US$714.9k | 12,200% | no data | |||
218,603 | US$603.3k | 0% | no data | |||
172,833 | US$477.0k | 19.5% | no data | |||
157,330 | US$434.2k | 399% | no data | |||
126,046 | US$347.9k | -83.7% | no data | |||
117,276 | US$323.7k | 122% | no data | |||
95,518 | US$263.6k | 775% | no data | |||
90,875 | US$250.8k | 68.2% | no data | |||
87,758 | US$242.2k | -1.17% | no data | |||
86,520 | US$238.8k | 775% | no data | |||
86,166 | US$237.8k | -45.3% | no data | |||
80,125 | US$221.1k | 8.83% | no data | |||
64,242 | US$177.3k | 6.16% | no data | |||
63,319 | US$174.8k | -90% | no data | |||
59,720 | US$164.8k | -0.49% | 0.03% | |||
59,070 | US$163.0k | 0% | no data | |||
58,948 | US$162.7k | -51.2% | 0.01% |